Armistice Capital, LLC In Med Pharmaceuticals Inc. Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.32 - $0.44 $19,520 - $26,840
61,000 Added 29.62%
266,968 $96,000
Q4 2023

Feb 13, 2024
BUY
$0.33 - $0.99 $67,969 - $203,908
205,968 New
205,968 $86,000
Q4 2022

Feb 14, 2023
BUY
$1.32 - $7.95 $9,455 - $56,945
7,163 Added 7.96%
97,163 $196,000
Q3 2022

Nov 14, 2022
BUY
$5.11 - $18.78 $459,900 - $1.69 Million
90,000 New
90,000 $593,000

Others Institutions Holding INM

# of Institutions
16
Shares Held
1.14M
Call Options Held
0
Put Options Held
0
View Full List

About InMed Pharmaceuticals Inc.

INM Quotes by TradingView
  • Ticker INM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 908,761
  • Market Cap $3.89M
  • Description
  • InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...
More about INM
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email